News list for "Novavax"
Novavax Pharmaceuticals (NVAX. O) took a short dive, widening its decline to 4 percent, as the Wall Street Journal reported that the company's COVID-19 vaccine is unlikely to be approved anytime soon.
Shares of Modena fell 4.4%, Pfizer fell 2%, Novavax fell nearly 1% and BioNTech fell 2.6%. The US Senate Finance Committee supported the nomination of "anti-vaccine" Kennedy Jr., the US health secretary.
Novavax Pharmaceuticals (NVAX. O) rose 52% in intraday trading and closed up nearly 99% on Friday.
Novavax Pharmaceuticals (NVAX. O) expanded premarket gains to more than 110 percent as the company reached a multi-billion dollar partnership with Sanofi.
Novavax Pharmaceuticals' US stock market jumped by more than 150% on May 10. On the news, the company announced a multi-billion dollar cooperation agreement with French pharmaceutical giant Sanofi. Under the agreement, the two parties will jointly commercialize Novavax Pharmaceuticals' COVID-19 vaccine starting next year and jointly develop a combination vaccine against coronavirus and influenza. Novavax CEO John Jacobs said the licensing agreement will help the company lift the "going concern" ...
Novavax Pharmaceuticals (NVAX. O) rose sharply before the market, expanding its gains to 200%.
Novavax Pharmaceuticals (NVAX. O) narrowed its premarket gains to 146 percent, having previously risen 217 percent.
